Anticancer drugs-induced apoptotic cell death in leukemia cells is associated with proteolysis of β-cateninHWANG, Sang-Gu; HYUNG CHUL LEE; TREPEL, Jane B et al.Leukemia research. 2002, Vol 26, Num 9, pp 863-871, issn 0145-2126Article

Pharmacodynamic Assessment of Histone Deacetylase Inhibitors : Infrared Vibrational Spectroscopic Imaging of Protein AcetylationTSOCHING CHEN; LEE, Min-Jung; YEONG SANG KIM et al.Analytical chemistry (Washington, DC). 2008, Vol 80, Num 16, pp 6390-6396, issn 0003-2700, 7 p.Article

Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpointKIM, Jung-Sik; PIRNIA, Farzaneh; MUSHINSKI, J. Frederic et al.Oncogene (Basingstoke). 2000, Vol 19, Num 52, pp 6082-6090, issn 0950-9232Article

Inhibition of tumor metastasis by a growth factor receptor bound protein 2 src homology 2 domain-binding antagonistGIUBEFLINO, Alessio; YANG GAO; LEE, Sunmin et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6012-6016, issn 0008-5472, 5 p.Article

Enhanced radiation-induced cell killing and prolongation of yH2AX foci expression by the histone deacetylase inhibitor MS-275CAMPHAUSEN, Kevin; BURGAN, William; CERRA, Michael et al.Cancer research (Baltimore). 2004, Vol 64, Num 1, pp 316-321, issn 0008-5472, 6 p.Article

Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingMOUSSES, Spyro; WAGNER, Urs; YIDONG CHEN et al.Oncogene (Basingstoke). 2001, Vol 20, Num 46, pp 6718-6723, issn 0950-9232Article

A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and LymphomasRAJAN, Arun; KELLY, Ronan J; MANNARGUDI, Baskar et al.Clinical cancer research (Print). 2011, Vol 17, Num 21, pp 6831-6839, issn 1078-0432, 9 p.Article

PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control cAMP response element-dependent transcription in response to nerve growth factor and cAMPCHANG, Jay H; VUPPALANCHI, Deepika; VAN NIEKERK, Erna et al.Journal of neurochemistry. 2006, Vol 99, Num 6, pp 1517-1530, issn 0022-3042, 14 p.Article

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphomaRYAN, Qin C; HEADLEE, Donna; MELILLO, Giovanni et al.Journal of clinical oncology. 2005, Vol 23, Num 17, pp 3912-3922, issn 0732-183X, 11 p.Article

Abrogation of p21 expression by Flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cellsNGUYEN, Dao M; SCHRUMP, William D; CHEN, G. Aaron et al.Clinical cancer research. 2004, Vol 10, Num 5, pp 1813-1825, issn 1078-0432, 13 p.Article

A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomasSOOK RYUN PARK; SPERANZA, Giovanna; STEINBERG, Seth M et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 4, pp 981-990, issn 0344-5704, 10 p.Article

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemiasGOJO, Ivana; JIEMJIT, Anchalee; GORE, Steven D et al.Blood. 2007, Vol 109, Num 7, pp 2781-2790, issn 0006-4971, 10 p.Article

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse modelsSHIBATA, Masa-Aki; KAVANAUGH, Claudine; SHIBATA, Eiko et al.Carcinogenesis (New York. Print). 2003, Vol 24, Num 3, pp 453-459, issn 0143-3334, 7 p.Article

MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor β type II receptor expression in human breast cancer cellsBYOUNG ICK LEE; SEOK HEE PARK; JIN WOO KIM et al.Cancer research (Baltimore). 2001, Vol 61, Num 3, pp 931-934, issn 0008-5472Article